These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 4262974)
21. Drug economics and the elderly: prescriptions for change. Lipton HL Bus Health; 1988 Mar; 5(5):8-11. PubMed ID: 10312402 [No Abstract] [Full Text] [Related]
22. The economics of drug prescribing in Ireland. O'Hanrahan M; O'Malley K Ir Med J; 1981 Oct; 74(10):309-10, 312. PubMed ID: 7309452 [No Abstract] [Full Text] [Related]
23. State and federal government mandates are changing the face of pharmacy management. Giaquinta D Manag Care Interface; 2001 May; 14(5):50-2. PubMed ID: 11385948 [No Abstract] [Full Text] [Related]
24. [Pharmaceutical economics and socialistic organization. 19. Needs and demands of the drug internal market]. Seidlein HJ Pharm Prax; 1970; 11():241-7. PubMed ID: 5494136 [No Abstract] [Full Text] [Related]
25. Drug costs. Holmes JD N Z Med J; 1977 Jul; 86(592):108-9. PubMed ID: 271877 [No Abstract] [Full Text] [Related]
26. Public policy considerations in the pricing of prescription drugs in the United States. Rucker TD Int J Health Serv; 1974; 4(1):171-9. PubMed ID: 4829895 [No Abstract] [Full Text] [Related]
28. The cost of prescription drugs: rising concerns over equity, fairness and access to essential care. Work DR; Domino ME N C Med J; 2003; 64(6):270-4. PubMed ID: 14983614 [No Abstract] [Full Text] [Related]
29. Study examines prescription fees and services offered by pharmacy. Schultz DP; Eckel FM; Gagnon JP Hospitals; 1977 May; 51(9):78-9, 82-5. PubMed ID: 404229 [No Abstract] [Full Text] [Related]
31. [The drug industry. A leading economic activity. 1. The companies The medication market]. Veylon R Nouv Presse Med; 1976 Jan; 5(2):97-101. PubMed ID: 1264652 [No Abstract] [Full Text] [Related]
32. [On the teaching of pharmacology. (II. Practical classes, examinations)]. Kharkevich DA Farmakol Toksikol; 1969; 32(2):244-50. PubMed ID: 5772153 [No Abstract] [Full Text] [Related]
33. Economic consequences of the maximum allowable cost program to the entire profession of pharmacy. Paul SH Med Mark Media; 1979 Aug; 14(8):19-26. PubMed ID: 10243270 [No Abstract] [Full Text] [Related]
34. Commercial production and distribution of contraceptives. Sollins AD Rep Popul Fam Plann; 1970 Jun; 4():1-23. PubMed ID: 5520685 [No Abstract] [Full Text] [Related]
35. Establishment of a nuclear pharmacy. Porter WC; Ice RD; Hetzel KR Am J Hosp Pharm; 1975 Oct; 32(10):1023-7. PubMed ID: 1190214 [TBL] [Abstract][Full Text] [Related]
36. Pharmaceutical expenditure compared across countries. van Mosseveld C Can J Clin Pharmacol; 2005; 12(3):e269-75. PubMed ID: 16373959 [TBL] [Abstract][Full Text] [Related]
37. The pharmacist's role in product selection. J Am Pharm Assoc; 1971 Apr; 11(4):181-99. PubMed ID: 5170866 [No Abstract] [Full Text] [Related]
38. The pharmaceutical market and prescription drugs in the Federal Republic of Germany: cross-national comparisons. Schicke RK Int J Health Serv; 1973; 3(2):223-36. PubMed ID: 4197751 [No Abstract] [Full Text] [Related]
39. Peddling drugs to docs. Heussner RC Minn Med; 1994 Jun; 77(6):24-31. PubMed ID: 8041331 [No Abstract] [Full Text] [Related]
40. How to pay less for prescription drugs. Consum Rep; 1975 Jan; 40(1):48-53. PubMed ID: 1244036 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]